1073-79-6

Basic information

• Product Name: 2,6-DIMETHYLTETRAHYDRO-4H-PYRAN-4-ONE
• Synonyms: dimethyltetrahydropyrone;tetrahydro-2,6-dimethyl-4h-pyran-4-on;2,6-Dimethyltetrahydro-4H-pyran-4-one 97%;Tetrahydro-2,6-dimethyl-4H-pyran-4-one;2,6-Dimethyltetrahydro-4-pyrone;2,6-dimethyloxan-4-one;2,6-dimethyltetrahydropyran-4-one;2,6-Dimethyl-4-oxotetrahydro-2H-pyran
• CAS NO: 1073-79-6
• Molecular Formula: C₇H₁₂O₂
• Molecular Weight: 128.17
• Product Categories: Ring Systems
• Mol File: 1073-79-6.mol

Chemical Properties

• Boiling Point: 177.6°C (rough estimate)
• Flash Point: 65.5°C
• Appearance: /
• Density: 0.9805 (rough estimate)
• Vapor Pressure: 0.71mmHg at 25°C
• Refractive Index: 1.4500 (estimate)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2,6-DIMETHYLTETRAHYDRO-4H-PYRAN-4-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-DIMETHYLTETRAHYDRO-4H-PYRAN-4-ONE(1073-79-6)
• EPA Substance Registry System: 2,6-DIMETHYLTETRAHYDRO-4H-PYRAN-4-ONE(1073-79-6)

Safety Data

• Hazard Codes: F
• Hazardous Substances Data: 1073-79-6(Hazardous Substances Data)

Usage

Uses

Used in Flavoring Agents:
2,6-Dimethyltetrahydro-4H-pyran-4-one is used as a flavoring agent for its pleasing aroma, which resembles the scent of tropical fruits such as apple and pineapple. It is incorporated into various food products to enhance their flavor profile.
Used in the Food Industry:
In the food industry, 2,6-Dimethyltetrahydro-4H-pyran-4-one is used as a flavoring agent to replicate the taste of tropical fruits in a range of products, including pastries, ice cream, candies, and beverages. This allows for a more authentic and enjoyable flavor experience for consumers.
Used in Safety Measures:
Due to its low acute toxicity, 2,6-Dimethyltetrahydro-4H-pyran-4-one requires appropriate handling measures to prevent skin and eye irritation. This ensures the safety of both the individuals working with the compound and the consumers who enjoy the products containing it.

InChI:InChI=1/C7H12O2/c1-5-3-7(8)4-6(2)9-5/h5-6H,3-4H2,1-2H3

Upstream product

• 1004-36-0 2,6-dimethylpyrone 
• 41866-70-0 2,6-dimethyl-4-hydroxy-2,3,5,6-tetrahydro-4H-pyran 
• 60-29-7 diethyl ether 

Downstream Products

• 928156-61-0 2-(trans-2,6-dimethyltetrahydro-2H-pyran-4-yl)acetic acid 
• 928156-60-9 2-((2R,6S)-2,6-dimethyltetrahydro-2H-pyran-4-yl)acetic acid 
• 41823-04-5 4-Ethinyl-2,6-dimethyl-tetrahydropyranol-4 
• 130724-84-4 4-(3-benzyloxyphenyl)-4-hydroxy-2,6-dimethyltetrahydropyran 

Relevant articles and documents

COMPOUNDS AND THEIR USE AS BACE INHIBITORS

The present application relates to compounds of formula (I), (la), or (lb) and their pharmaceutical compositions/preparations. This application further relates to methods of treating or preventing Αβ-related pathologies such as Down's syndrome, β- amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI ("mild cognitive impairment"), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia, including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease.

2-CYANOPYRROLIDINECARBOXAMIDE COMPOUND

A compound of the formula (I) or a pharmaceutically acceptable salt thereof: [wherein X1 and X2 each is independently lower alkylene; X3 is =CH2, =CHF or =CF2; R1 is substituent, R2 and R3 each is independently H or lower alkyl; n is 0, 1, 2, 3 or 4.] having the activity inhibiting DPP-IV activity. They are therefore useful in the treatment of conditions mediated by DPP-IV, such as NIDDM.

Antibiotic oxazolidinone derivatives

The invention concerns a compound of the formula (I): wherein, for example: R1is of the formula —NHC(═O)Rbwherein Rbis, for example, (1-4C)alkyl; R2and R3are hydrogen or fluoro; R2and R3are hydrogen or fluoro; D is O; R4and R5are hydrogen, (1-4C)alkyl or AR-oxymethyl; AR is phenyl or phenyl(1-4C)alkyl; R6is hydrogen; >A—B— is of the formula >C═C(Ra)—, >CHCHRa—, or >C(OH)CHRa— (> represents two single bonds) wherein Rais hydrogen or (1-4C)alkyl; and pharmaceutically-acceptable salts thereof; processes for their preparation; pharmaceutical compositions containing them and their use as antibacterial agents.

Antibiotic oxazolidinone derivatives

The invention concerns a compound of formula (I): STR1 wherein R1 -R6, A, B, and D have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising

Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis

Compounds having the formula I: STR1 are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.

Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis

Compounds having the formula I: STR1 are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis and allograft rejection and in preventing the formation of atherosclerotic plaques.